Indústrias Romi S.A (ROMI3)
B3 Stock Exchange · Brazil · prices in BRL · close of 23 Oct 2026
Key indicators
| Last close | BRL 7.630 |
|---|---|
| 52-week range | 5.430 – 8.920 |
| Return, 1 month / 3 months | +26.7% / +30.4% |
| Return, 1 year / 3 years | −4.5% / −16.7% |
| Trend | Uptrend |
| RSI (14) | 71 |
| Volatility (1 year) | 26.2% |
| Worst drawdown (1 year) | -37.4% |
| Average daily value traded | 1.66M BRL |
| Dividend yield | 3.1% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Indústrias Romi is a Brazilian industrial company that builds machine tools and plastic processing equipment. It makes lathes, machining centres and other metal-cutting machines, along with injection moulding machines for plastics, and it also produces castings and provides related services. Its customers are manufacturers and industrial firms that use this equipment in their production processes. The company is based in Santa Bárbara d'Oeste, in the state of São Paulo, and supplies customers in Brazil and abroad.
On this site Indústrias Romi S.A appears as a stock on the B3 Stock Exchange (Brazil), code ROMI3, with prices in Brazilian reais (BRL). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Indústrias Romi S.A (ROMI3) trades on the B3 Stock Exchange in Brazil. It last closed at BRL 7.630 on 23 October 2026.
Its price-based Market X-Ray is 57 out of 100 (a fair price profile), ranking 507 of 1,455 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 4.5% and over the last three months it rose 30.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on B3 Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 47 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | 11.9% | ||
| From 52-week high | -13.0% | ||
| Momentum | 54 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 30.4% | ||
| 6-month return | 10.1% | ||
| 12-month return, skipping the last month | -24.7% | ||
| Stability (higher is calmer) | 59 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 26.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -37.4% | ||
| Liquidity | 78 · Strong | Trades actively. | |
| Average daily value traded | 1.66M BRL | ||
| Zero-volume days | 0.0% | ||
| Income | 53 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 3.1% | ||
| Years with dividends | 6 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
Returns
| 1 week | +4.5% |
|---|---|
| 1 month | +26.7% |
| 3 months | +30.4% |
| 6 months | +10.1% |
| 1 year | −4.5% |
| 3 years | −16.7% |
| 5 years | −26.8% |
Signals
| 50-day / 200-day average | 6.158 / 6.820 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.299 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 15 Jun 2026 | BRL 0.0600 |
| 30 Dec 2025 | BRL 0.1800 |
| 22 Sep 2025 | BRL 0.1800 |
| 16 Jun 2025 | BRL 0.1800 |
| 17 Mar 2025 | BRL 0.1800 |
| 16 Dec 2024 | BRL 0.2200 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on B3 Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.